MSLE

Satellos Bioscience Inc.

Healthcare · Biotechnology

$67.88 sample

+0.47 (+0.70%) 1D

Market cap

$85.9B

Price as of

2026-10-03

Latest filing

8-K · 2026-09-16

Alerts

8

Price$67.88 -5.46% 3M daily closessample

73.8264.70

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 28INSInsider sell: Chief Financial Officer
Sep 23INSInsider sell: General Counsel
Sep 16SECForm 144 filed
Sep 11INSInsider buy: Director
Sep 08SEC10-Q filed
Sep 01INSInsider sell: Chief Financial Officer
Aug 25INSInsider sell: Chief Financial Officer
Aug 19INSInsider sell: EVP, Operations

Sign up to see the real MSLE record →

Company facts

SEC EDGAR registration

Name: Satellos Bioscience Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +49sample, -100 to +100
Reporting currency: USD

Who is positioning in MSLE

sample

Insiders: 7 insider transactions over 90 days, net selling, $833.7M
Congress: 1 members traded over 90 days
Institutions · 13F: 22 funds hold $1.2B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$2.7B +15.3% y/y

Q4 2024Q3 2026

Inventory$1.7B +14.5% y/y

Q4 2024Q3 2026

Accounts receivable$1.2B +7.8% y/y

Q4 2024Q3 2026

Total debt$3.4B +18.2% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $22.3B -7.1% 3M
Sample peer B: $36.7B +9.7% 3M
Sample peer C: $61.6B +10.9% 3M
Sample peer D: $52.0B +4.6% 3M
Sample peer E: $57.7B -6.3% 3M